Flex Pharma Announces Reduction of Muscle Cramping in Athletes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Flex Pharma (FLKS) Announces Statistically Significant Data from Muscle Cramp Study
July 7, 2015 9:24 AM EDTFlex Pharma (NASDAQ: FLKS) announced its proprietary treatment prevented muscle cramps in an initial study of athletes participating in high intensity sports.
We believe this is the first time any consumer beverage has shown a statistically significant reduction of naturally occurring muscle cramps in... More
